Submitted by Anonymous (not verified) on 12 October 2023 - 14:20
Opinion/decision on a Paediatric investigation plan (PIP): Enspryng,satralizumab, decision type: , therapeutic area: , PIP number: P/0448/2022
Source:
Opinion/decision on a Paediatric investigation plan (PIP): Enspryng,satralizumab, decision type: , therapeutic area: , PIP number: P/0448/2022